204 related articles for article (PubMed ID: 28056053)
1. Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality.
Lange A; Sundén-Cullberg J; Magnuson A; Hultgren O
PLoS One; 2017; 12(1):e0169176. PubMed ID: 28056053
[TBL] [Abstract][Full Text] [Related]
2. Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis.
Lange A; Cajander S; Magnuson A; Strålin K; Hultgren O
PLoS One; 2022; 17(3):e0265818. PubMed ID: 35312715
[TBL] [Abstract][Full Text] [Related]
3. Application of monoclonal antibodies in a sandwich enzyme-linked immunosorbent assay for identification and detection of soluble human B and T lymphocyte attenuator.
Wang X; Zhu G; Huang Z; Cao L; Chen Y; Wang Q; Zhang X
Hybridoma (Larchmt); 2012 Dec; 31(6):417-23. PubMed ID: 23244320
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of soluble B and T lymphocyte attenuator predict overall survival in patients undergoing immune checkpoint inhibitor therapy for solid malignancies.
Gorgulho J; Roderburg C; Heymann F; Schulze-Hagen M; Beier F; Vucur M; Kather JN; Laleh NG; Tacke F; Brümmendorf TH; Luedde T; Loosen SH
Int J Cancer; 2021 Sep; 149(5):1189-1198. PubMed ID: 33890289
[TBL] [Abstract][Full Text] [Related]
5. Increased Expression of Programmed Cell Death-1 in Regulatory T Cells of Patients with Severe Sepsis and Septic Shock: An Observational Clinical Study.
Liu Q; An L; Qi Z; Zhao Y; Li C
Scand J Immunol; 2017 Nov; 86(5):408-417. PubMed ID: 28888058
[TBL] [Abstract][Full Text] [Related]
6. Low B and T lymphocyte attenuator expression on CD4+ T cells in the early stage of sepsis is associated with the severity and mortality of septic patients: a prospective cohort study.
Shao R; Li CS; Fang Y; Zhao L; Hang C
Crit Care; 2015 Aug; 19(1):308. PubMed ID: 26329820
[TBL] [Abstract][Full Text] [Related]
7. Plasma kallistatin in critically ill patients with severe sepsis and septic shock.
Lin WC; Chen CW; Chao L; Chao J; Lin YS
PLoS One; 2017; 12(5):e0178387. PubMed ID: 28542440
[TBL] [Abstract][Full Text] [Related]
8. Changes in the process of alternative RNA splicing results in soluble B and T lymphocyte attenuator with biological and clinical implications in critical illness.
Monaghan SF; Banerjee D; Chung CS; Lomas-Neira J; Cygan KJ; Rhine CL; Fairbrother WG; Heffernan DS; Levy MM; Cioffi WG; Ayala A
Mol Med; 2018 Jun; 24(1):32. PubMed ID: 30134817
[TBL] [Abstract][Full Text] [Related]
9. The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department.
Zhao Y; Jia Y; Li C; Fang Y; Shao R
Am J Emerg Med; 2018 Jan; 36(1):43-48. PubMed ID: 28716595
[TBL] [Abstract][Full Text] [Related]
10. Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.
Zhao Y; Jia Y; Li C; Shao R; Fang Y
Shock; 2019 Mar; 51(3):289-297. PubMed ID: 29702526
[TBL] [Abstract][Full Text] [Related]
11. Serum sPD-L1, Upregulated in Sepsis, May Reflect Disease Severity and Clinical Outcomes in Septic Patients.
Liu M; Zhang X; Chen H; Wang G; Zhang J; Dong P; Liu Y; An S; Wang L
Scand J Immunol; 2017 Jan; 85(1):66-72. PubMed ID: 27864994
[TBL] [Abstract][Full Text] [Related]
12. Monocyte programmed death ligand-1 expression after 3-4 days of sepsis is associated with risk stratification and mortality in septic patients: a prospective cohort study.
Shao R; Fang Y; Yu H; Zhao L; Jiang Z; Li CS
Crit Care; 2016 May; 20(1):124. PubMed ID: 27156867
[TBL] [Abstract][Full Text] [Related]
13. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Greisen SR; Rasmussen TK; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Hvid M; Deleuran B
Scand J Rheumatol; 2014; 43(2):101-8. PubMed ID: 24182347
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of chemokine ligand 20 and chemokine receptor 6 in patients with sepsis: A case control study.
Klaus DA; Seemann R; Roth-Walter F; Einwallner E; Motal MC; Tudor B; Lebherz-Eichinger D; Wiegele M; Krenn CG; Roth GA
Eur J Anaesthesiol; 2016 May; 33(5):348-55. PubMed ID: 26771764
[TBL] [Abstract][Full Text] [Related]
15. The Cold-Inducible RNA-Binding Protein (CIRP) Level in Peripheral Blood Predicts Sepsis Outcome.
Zhou Y; Dong H; Zhong Y; Huang J; Lv J; Li J
PLoS One; 2015; 10(9):e0137721. PubMed ID: 26361390
[TBL] [Abstract][Full Text] [Related]
16. A combination of early warning score and lactate to predict intensive care unit transfer of inpatients with severe sepsis/septic shock.
Yoo JW; Lee JR; Jung YK; Choi SH; Son JS; Kang BJ; Park TS; Huh JW; Lim CM; Koh Y; Hong SB
Korean J Intern Med; 2015 Jul; 30(4):471-7. PubMed ID: 26161013
[TBL] [Abstract][Full Text] [Related]
17. B and T lymphocyte attenuator expression on CD4+ T-cells associates with sepsis and subsequent infections in ICU patients.
Shubin NJ; Monaghan SF; Heffernan DS; Chung CS; Ayala A
Crit Care; 2013 Nov; 17(6):R276. PubMed ID: 24289156
[TBL] [Abstract][Full Text] [Related]
18. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.
van Vught LA; Klein Klouwenberg PM; Spitoni C; Scicluna BP; Wiewel MA; Horn J; Schultz MJ; Nürnberg P; Bonten MJ; Cremer OL; van der Poll T;
JAMA; 2016 Apr; 315(14):1469-79. PubMed ID: 26975785
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating soluble immune checkpoint proteins in sorafenib-treated patients with advanced hepatocellular carcinoma.
Dong MP; Enomoto M; Thuy LTT; Hai H; Hieu VN; Hoang DV; Iida-Ueno A; Odagiri N; Amano-Teranishi Y; Hagihara A; Fujii H; Uchida-Kobayashi S; Tamori A; Kawada N
Sci Rep; 2020 Feb; 10(1):3392. PubMed ID: 32099055
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: Observational FINNAKI cohort study.
Ala-Kokko TI; Mutt SJ; Nisula S; Koskenkari J; Liisanantti J; Ohtonen P; Poukkanen M; Laurila JJ; Pettilä V; Herzig KH;
Ann Med; 2016; 48(1-2):67-75. PubMed ID: 26800186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
